Management of Cholestatic Liver Enzymes

Initial Diagnostic Workup

The American Association for the Study of Liver Diseases recommends verifying that alkaline phosphatase (ALP) is elevated >1.5× upper limit of normal (ULN) with gamma-glutamyltransferase (GGT) >3× ULN to confirm hepatobiliary origin 2
The European Association for the Study of the Liver notes that GGT elevations occur earlier and persist longer than ALP in cholestatic disorders, but isolated GGT elevation lacks specificity and may reflect alcohol or drug-induced enzyme induction 3, 2
If ALP source is unclear, the American Gastroenterological Association recommends obtaining ALP fractionation to confirm hepatic origin 3

The American College of Gastroenterology recommends that ultrasound is mandatory as the initial imaging to identify bile duct dilation and exclude mechanical obstruction 1
This distinguishes extrahepatic (dilated ducts) from intrahepatic cholestasis (normal ducts) 4, 1

The American Association for the Study of Liver Diseases recommends proceeding with MRCP or endoscopic ultrasound (EUS) rather than proceeding directly to ERCP, to avoid unnecessary complications (bleeding 2%, cholangitis 1%, pancreatitis 3-5%, mortality 0.4%) 1, 5
MRCP has 96-100% sensitivity for detecting bile duct stones 1, 5
The European Association for the Study of the Liver recommends reserving ERCP for therapeutic intervention only (sphincterotomy and stone extraction) once obstruction is confirmed 1, 5

The American Gastroenterological Association recommends obtaining detailed medication history including prescribed drugs, over-the-counter medications, herbal supplements, and illicit substances, as drug-induced cholestasis is a common cause, especially in elderly patients 3, 4
ALP >2× baseline warrants increased monitoring unless alternative explanation exists 3
ALP >3× baseline OR ALP >2× baseline with bilirubin >2× ULN or symptoms should trigger drug interruption 3

The American Association for the Study of Liver Diseases recommends measuring direct (conjugated) bilirubin fraction to distinguish DILI (usually >35% direct) from Gilbert's syndrome (<20-30% conjugated) 3
Gilbert's syndrome affects 5-10% of population and causes intermittent unconjugated hyperbilirubinemia, rarely >4-5 mg/dL 3

The American College of Gastroenterology recommends first-line treatment with Cholestyramine for pruritus management 1
The European Association for the Study of the Liver recommends second-line treatment with Rifampicin for pruritus management 1
The American Gastroenterological Association recommends third-line treatment with Naltrexone for pruritus management 1

The American Association for the Study of Liver Diseases recommends referring immediately to hepatology for hepatitis B (HBsAg positive) or hepatitis C (antibody and PCR positive) 4
The European Association for the Study of the Liver recommends referring immediately to hepatology for autoimmune hepatitis (elevated IgG with positive autoantibodies) 4
The American College of Gastroenterology recommends referring immediately to hepatology for primary biliary cholangitis (cholestatic enzymes with positive AMA) 6
The American Gastroenterological Association recommends referring immediately to hepatology for hemochromatosis (elevated ferritin with transferrin saturation >45%) 4

The American Association for the Study of Liver Diseases recommends considering liver transplantation when hepatocellular failure or portal hypertension complications occur, as transplantation is the definitive treatment for advanced cholestatic liver disease 1